Abstract Background Transthyretin Amyloid Cardiomyopathy (ATTR-CM) is an under-diagnosed condition often presenting with Heart Failure (HF). We aimed to assess a cohort of patients ATTR-CM and HF, focusing on the centre strategies identify new cases, prognosticate tailor treatment. Methods conducted all-comers single-centre prospective registry consecutive HF due followed in our from November 2...